Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
acetylsalicylic acid (aspirin) (1 trial)
aflibercept (zaltrap) (1 trial)
bevacizumab (avastin) (1 trial)
dexamethasone (3 trials)
ketorolac (acuvail) (1 trial)
ranibizumab (lucentis) (3 trials)
ropivacaine (naropin) (1 trial)
mifepristone (mifeprex) (1 trial)
urea (2 trials)
verteporfin (visudyne) (1 trial)
amino acids (Freamine) (1 trial)
hemoglobin (1 trial)
melatonin (1 trial)
vitamin c (1 trial)
zeolite (1 trial)
Cataract (Phase 4)
Central Serous Chorioretinopathy (Phase 2)
Edema (Phase 4)
Macular Degeneration (Phase 2)
Macular Edema (Phase 4)
Pain, Postoperative (Phase 4)
Wet Macular Degeneration (Phase 2)
Trials (12 total)
Trial APIs (15 total)